Can robotics and artificial intelligence (AI) make rehabilitation care more affordable and accessible in India? Early-stage investment fund 1Crowd has invested in Rymo Technologies, a health-tech company developing robotic rehabilitation systems and AI-powered solutions to improve physical therapy.
The investment aims to address gaps in India’s rehabilitation ecosystem by making advanced rehabilitation technology more accessible to hospitals, physiotherapy clinics and rehabilitation centres. Rymo develops technology-driven solutions that help clinicians deliver consistent, data-based therapy to patients recovering from neurological and orthopaedic conditions.
Making Robotic Rehabilitation More Affordable
Imported robotic rehabilitation systems can cost between ₹1 crore and ₹1.5 crore, creating affordability challenges for many healthcare providers. In comparison, Rymo claims its solutions are up to 10 times more affordable than imported alternatives.
According to 1Crowd, Rymo’s products cost around 10–20 per cent of what foreign competitors charge. This pricing strategy could help smaller physiotherapy centres and mid-sized hospitals adopt advanced rehabilitation technology without making significant investments. Moreover, the company aims to bring these solutions closer to patients by expanding access beyond large metropolitan hospitals.
Product Portfolio Combines Robotics, AI and Virtual Reality
Rymo Technologies offers a range of rehabilitation solutions, including robotic rehabilitation systems, balance trainers, extended reality (XR) and virtual reality (VR)-based devices. The company is also developing functional electrical stimulation (FES) devices.
By combining robotics, AI and gamification, Rymo aims to make rehabilitation programmes more engaging while helping clinicians monitor patient progress more effectively. These technologies support structured therapy and improved tracking across hospitals, physiotherapy clinics and rehabilitation centres.
Healthcare and Medtech Drive 1Crowd’s Investments
Natasha Kothari, Co-Founder and Partner at 1Crowd, said the fund supports businesses that use technology to address gaps in healthcare access and delivery.
Healthcare and medical technology account for approximately 20 per cent of 1Crowd’s investment portfolio. The fund has also invested in around 10 health-tech companies operating across biotechnology, healthcare insurance and financing, and medical devices.
The investment in Rymo Technologies reflects the growing interest in technology-driven rehabilitation solutions that can improve access to advanced physical therapy while reducing equipment costs. As reported by thehindubusinessline.com, 1Crowd has invested in Rymo Technologies to expand access to affordable robotic rehabilitation solutions in India.